Guardion Health Sciences (GHSI) is an American company focused on developing and commercializing diagnostic technologies and nutritional supplements. Its main product, map-5, is a diagnostic test for detecting macular degeneration, an eye disease associated with vision loss. The company also focuses on researching and developing other diagnostic tests and therapeutic products aimed at improving eye health and preventing eye diseases. Guardion Health Sciences (GHSI) shares may be suitable for investors seeking exposure to the healthcare and diagnostic technologies sector with growth potential in the healthcare products market.
Feed
There are no posts to show right now.
Używamy ciasteczek, aby ulepszyć Twoje doświadczenie na naszej stronie.
